In the realm of chemical synthesis, particularly within the pharmaceutical industry, the quality of starting materials and intermediates directly dictates the success of the entire process. For advanced compounds like 4-methoxybenzyl (6R,7R)-7-amino-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride (CAS: 113479-65-5), ensuring impeccable purity and adherence to exact specifications is not merely a preference, but a critical requirement.

This specific intermediate, vital for the development of therapeutic agents, presents unique challenges in its synthesis and purification. As a manufacturer, we understand that our role extends beyond simply producing a chemical; it involves guaranteeing a consistent and reliable supply of a compound that meets the rigorous demands of pharmaceutical R&D and production. The molecular structure, C16H18Cl2N2O4S, with a molecular weight of 405.30, and its characteristic pale yellow solid appearance, are just the surface markers of its critical nature.

For research scientists and product formulators, selecting a supplier who prioritizes quality is paramount when they look to buy this intermediate. Opting for a manufacturer with robust quality control systems means fewer batch-to-batch variations, reduced risk of side reactions due to impurities, and ultimately, a more efficient and predictable synthesis. This is particularly true when this compound is used as a key building block for complex pharmaceuticals, such as certain classes of antibiotics.

Engaging with a reputable China-based manufacturer like ourselves provides an opportunity to access high-quality intermediates at competitive prices. Our commitment to excellence in production and our efficient logistics network ensure that whether you require gram quantities for research or bulk orders for manufacturing, your needs are met with professionalism and promptness. We encourage prospective buyers to inquire about our product specifications and to request a detailed quote to understand our value proposition.

The pursuit of optimized chemical synthesis begins with the foundational elements. By choosing to partner with a reliable supplier for intermediates like CAS 113479-65-5, pharmaceutical companies and research institutions can significantly de-risk their development processes, accelerate timelines, and ensure the high quality of their end products, contributing to better patient outcomes worldwide.